1.Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions andAssumptions 2.Executive Summary 3.Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4.Key Insights 4.1 Brand Analysis 4.2 Key IndustryDevelopments - Mergers, Acquisitions and Partnerships 4.3 Reimbursement Scenario 4.4 Key PerformanceIndicators 5.Global Thrombin Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis,Insights and Forecast – By Product 5.2.1 Bovine Thrombin 5.2.2 Human Thrombin 5.2.3 Recombinant Thrombin 5.3. Market Analysis,Insights and Forecast – By Dosage Form 5.3.1 Powder Form 5.3.2 Solution Form 5.4. Market Analysis,Insights and Forecast – By End User 5.4.1 Hospitals 5.4.2 Diagnostics Centers & Clinics 5.4.3 Academics and Research Institutes 5.5. Market Analysis,Insights and Forecast – By Region 5.5.1 North America 5.5.2 Europe 5.5.3 Asia Pacific 5.5.4 Rest of the World 6.North America Thrombin Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis,Insights and Forecast – By Product 6.2.1 Bovine Thrombin 6.2.2 Human Thrombin 6.2.3 Recombinant Thrombin 6.3. Market Analysis,Insights and Forecast – By Dosage Form 6.3.1 Powder Form 6.3.2 Solution Form 6.4. Market Analysis,Insights and Forecast – By End User 6.4.1 Hospitals 6.4.2 Diagnostics Centers & Clinics 6.4.3 Academics and Research Institutes 6.5. Market Analysis,Insights and Forecast – By Country 6.5.1 USA 6.5.2 Canada 7.Europe Thrombin Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis,Insights and Forecast – By Product 7.2.1 Bovine Thrombin 7.2.2 Human Thrombin 7.2.3 Recombinant Thrombin 7.3. Market Analysis,Insights and Forecast – By Dosage Form 7.3.1 Powder Form 7.3.2 Solution Form 7.4. Market Analysis,Insights and Forecast – By End User 7.4.1 Hospitals 7.4.2 Diagnostics Centers & Clinics 7.4.3 Academics and Research Institutes 7.5. Market Analysis,Insights and Forecast – By Country/ Sub-region 7.5.1 UK 7.5.2 Germany 7.5.3 France 7.5.4 Italy 7.5.5 Spain 7.5.6 Rest of the World 8.Asia Pacific Thrombin Market Analysis,Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis,Insights and Forecast – By Product 8.2.1 Bovine Thrombin 8.2.2 Human Thrombin 8.2.3 Recombinant Thrombin 8.3. Market Analysis,Insights and Forecast – By Dosage Form 8.3.1 Powder Form 8.3.2 Solution Form 8.4. Market Analysis,Insights and Forecast – By End User 8.4.1 Hospitals 8.4.2 Diagnostics Centers & Clinics 8.4.3 Academics and Research Institutes 8.5. Market Analysis,Insights and Forecast – By Country/ Sub-region 8.5.1 Japan 8.5.2 China 8.5.3 Australia 8.5.4 Rest of Asia Pacific 9.Rest of the World Thrombin Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis,Insights and Forecast – By Product 9.2.1 Bovine Thrombin 9.2.2 Human Thrombin 9.2.3 Recombinant Thrombin 9.3. Market Analysis, Insights and Forecast – By Dosage Form 9.3.1 Powder Form 9.3.2 Solution Form 9.4. Market Analysis,Insights and Forecast – By End User 9.4.1 Hospitals 9.4.2 Diagnostics Centers& Clinics 9.4.3 Academics and Research Institutes 9.5. Market Analysis,Insights and Forecast – By Country/ Sub-region 10.Competitive Analysis 10.1. Key Industry Developments 10.2. Global Market Share Analysis (2018) 10.3. Competition Dashboard 10.4. Comparative Analysis –Major Players 10.5. Company Profiles(Overview, Products & Services, SWOT Analysis, Recent Developments,Strategies, Financials (based on availability) 10.5.1 Pfizer Inc. 10.5.2 Johnson & Johnson Services Inc. 10.5.3 Baxter 10.5.4 Shanghai RAAS blood products co. Ltd. 10.5.5 Japan Blood Products Organization 10.5.6 Mochida Pharmaceutical Co. Ltd. 10.5.7 Other prominent players 11.Strategic Recommendations

Pfizer Inc. Johnson & Johnson Services Inc. Baxter Shanghai RAAS blood products co. Ltd. Japan Blood Products Organization Mochida Pharmaceutical Co. Other prominent players